Skip to main content

12 Result(s)

within A. Thiebaut Remove this filter

and

  1. No Access

    Article

    Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimen

    Bevacizumab has demonstrated activity in patients with recurrent glioblastoma. However, the impact of prognostic factors associated with recurrent glioblastoma treated with cytotoxic agents has not been determ...

    E. Tabouret, M. Barrie, A. Thiebaut, M. Matta, C. Boucard… in Journal of Neuro-Oncology (2013)

  2. No Access

    Article

    European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

    In 2005, several groups, including the European Group for Blood and Marrow Transplantation, the European Organization for Treatment and Research of Cancer, the European Leukemia Net and the Immunocompromised H...

    J Maertens, O Marchetti, R Herbrecht, O A Cornely… in Bone Marrow Transplantation (2011)

  3. No Access

    Article

    Necrotizing Gastritis due to Bacillus cereus in an Immunocompromised Patient

    Bacillus cereus is increasingly being acknowledged as a serious bacterial pathogen in immunocompromised patients. We present a case of acute necrotizing gastritis caused by B. cereus in a 37-year-old woman with a...

    J. Le Scanff, I. Mohammedi, A. Thiebaut, O. Martin, L. Argaud, D. Robert in Infection (2006)

  4. No Access

    Article

    Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformation

    T Prebet, A-S Michallet, C Charrin, S Hayette, J-P Magaud… in Bone Marrow Transplantation (2004)

  5. No Access

    Chapter and Conference Paper

    Phase I Clinical Evaluation of Topotecan Combined with Idarubicin and Cytarabine in Patients with Refractory or Relapsed Acute Myeloid Leukemia

    Topotecan is a semisynthetic water-soluble camptothecin analog that targets the nuclear enzyme topoisomerase I. Topotecan stabilizes a covalent DNA-topoisomerase I complex to yield enzyme-linked, reversible DN...

    X. Thomas, A. Belhabri, A. Thiebaut, Y. Chelghoum, M. Elhamri… in Acute Leukemias IX (2003)

  6. No Access

    Article

    Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM)

    To assess the place of allogeneic hematopoietic stem cell transplantation (HSCT) in the advanced stage of acute myeloid leukemia (AML), we retrospectively analyzed 379 consecutive patients who underwent alloge...

    M Michallet, X Thomas, JP Vernant, M Kuentz, G Socié… in Bone Marrow Transplantation (2000)

  7. No Access

    Article

    Late autologous transplantation in chronic myelogenous leukemia with peripheral blood progenitor cells mobilized by G-CSF and interferon-α

    In chronic myelogenous leukemia (CML), autologous stem cell transplantation could be a promising new approach for patients with no cytogenetic response after interferon α (IFN-α) therapy. We report data on 28 ...

    M Michallet, A Thiébaut, I Philip, C Charrin, C Vigouroux, X Thomas, K Bilger… in Leukemia (2000)

  8. No Access

    Article

    Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis

    /l were scheduled to undergo leukapheresis. This represented 53 patients (median age 59 years, range 16–78 years) who underwent from 1 to 4 sets of leukapheresis (median 1). The median initial WBC count was 16...

    A. Thiébaut, X. Thomas, A. Belhabri, B. Anglaret, E. Archimbaud in Annals of Hematology (2000)

  9. No Access

    Chapter and Conference Paper

    Idarubicin and Ifosfamide in the Treatment of Refractory and Relapsed Acute Lymphoblastic Leukemia

    22 adult patients with relapsed ALL and 2 with refractory ALL were treated in a cooperative trial with an association of idarubicin, ifosfamide, and dexamethasone. Complete remission was achieved in 7 relapsed...

    X. Thomas, F. Bauduer, A. Thiebaut, A. Brion, F. Maloisel, P. Fenaux… in Acute Leukemias VII (1998)

  10. No Access

    Article

    Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy

     With the aim of determining the ability of all-trans retinoic acid (ATRA) to improve prognosis in refractory and relapsed acute promyelocytic leukemia (APL), the data of 45 patients resistant to previous convent...

    X. Thomas, B. Anglaret, A. Thiebaut, A. Belhabri… in Annals of Hematology (1997)

  11. No Access

    Article

    Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias

    Recurrent anomalies of the short arm of chromosome 9, including interstitial deletions and translocations, have often been described. Recently two cyclin-dependent kinase inhibitors, known as P16 (INK4A/MTS1) and...

    S Hayette, X Thomas, Y Bertrand, I Tigaud, M Callanan, A Thiebaut, C Charrin… in Leukemia (1997)

  12. No Access

    Article

    Bipolar fixation of fractures of the distal end of the radius

    The frequency of secondary displacement in fractures of the distal end of the radius is very high and varies from 40 to 60% in various series. This results from the void in the epiphysis after reduction due to...

    A. Rauïs, A. Ledoux, A. Thiebaut, M. van der Ghinst in International Orthopaedics (1979)